Indication
von Willebrand disease and Hemophilia
1 clinical trial
1 product
Clinical trial
Emicizumab for Severe VON Willebrand Disease (VWD) and VWD/Hemophilia AStatus: Recruiting, Estimated PCD: 2025-11-01
Product
Emicizumab1 clinical trial
1 product